These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 32577584)
21. Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic Retinopathy. Wykoff CC; Chakravarthy U; Campochiaro PA; Bailey C; Green K; Cunha-Vaz J Ophthalmology; 2017 Apr; 124(4):440-449. PubMed ID: 28081945 [TBL] [Abstract][Full Text] [Related]
22. Health-economic evaluation of fluocinolone acetonide 190 µg implant in people with diabetic macular edema. Holden SE; Currie CJ; Owens DR Curr Med Res Opin; 2017 Oct; 33(sup2):45-52. PubMed ID: 28881146 [TBL] [Abstract][Full Text] [Related]
23. BILATERAL INTRAVITREAL 0.19-MG FLUOCINOLONE ACETONIDE IMPLANT FOR PERSISTENT NONDIABETIC CYSTOID MACULAR EDEMA AFTER VITRECTOMY. Ong SS; Walter SD; Chen X; Thomas AS; Finn AP; Fekrat S Retin Cases Brief Rep; 2021 May; 15(3):261-265. PubMed ID: 30015770 [TBL] [Abstract][Full Text] [Related]
24. Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies. Khurana RN; Appa SN; McCannel CA; Elman MJ; Wittenberg SE; Parks DJ; Ahmad S; Yeh S Ophthalmology; 2014 Jan; 121(1):67-71. PubMed ID: 23890421 [TBL] [Abstract][Full Text] [Related]
25. Fluocinolone acetonide 0.19 mg intravitreal implant improves foveal thickness and reduces treatment burden for up to 1 year in eyes with persistent diabetic macular edema. Coney JM Int Med Case Rep J; 2019; 12():161-169. PubMed ID: 31213929 [No Abstract] [Full Text] [Related]
26. Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report. Pacella F; Agostinelli E; Carlesimo SC; Nebbioso M; Secondi R; Forastiere M; Pacella E J Med Case Rep; 2016 Oct; 10(1):282. PubMed ID: 27733187 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of the clinical effectiveness of fluocinolone acetonide 190 µg intravitreal implant in diabetic macular edema: a comparison between study and fellow eyes. Currie CJ; Holden SE; Berni E; Owens DR Curr Med Res Opin; 2017 Oct; 33(sup2):19-31. PubMed ID: 28881143 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study. Massin P; Erginay A; Dupas B; Couturier A; Tadayoni R Clin Ophthalmol; 2016; 10():1257-64. PubMed ID: 27468222 [TBL] [Abstract][Full Text] [Related]
29. Optical Coherence Tomography Biomarkers of Inflammation in Diabetic Macular Edema Treated by Fluocinolone Acetonide Intravitreal Drug-Delivery System Implant. Arrigo A; Capone L; Lattanzio R; Aragona E; Zollet P; Bandello F Ophthalmol Ther; 2020 Dec; 9(4):971-980. PubMed ID: 32914324 [TBL] [Abstract][Full Text] [Related]
30. Three-year results from the Retro-IDEAL study: Real-world data from diabetic macular edema (DME) patients treated with ILUVIEN Augustin AJ; Bopp S; Fechner M; Holz F; Sandner D; Winkgen AM; Khoramnia R; Neuhann T; Warscher M; Spitzer M; Sekundo W; Seitz B; Duncker T; Ksinsik C; Höh H; Gentsch D Eur J Ophthalmol; 2020 Mar; 30(2):382-391. PubMed ID: 30884972 [TBL] [Abstract][Full Text] [Related]
31. The 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema: An Expert Consensus. Kolomeyer AM; Eichenbaum DA; Kiernan DF; Suñer IJ; Hariprasad SM Ophthalmic Surg Lasers Imaging Retina; 2023 Mar; 54(3):166-173. PubMed ID: 36944067 [TBL] [Abstract][Full Text] [Related]
32. Long-Term Follow-Up of Patient with Diabetic Macular Edema Receiving Fluocinolone Acetonide Intravitreal Implant. Bertelmann T; Schulze S Ophthalmol Ther; 2015 Jun; 4(1):51-8. PubMed ID: 25672501 [TBL] [Abstract][Full Text] [Related]
33. Preserflo Microshunt Surgery for Ocular Hypertension following Intravitreal Fluocinolone Acetonide Implant Removal: A Case Report. Rezkallah A; Loria O; Mathis T; Chacun S; Denis P; Kodjikian L Case Rep Ophthalmol; 2022; 13(3):1024-1029. PubMed ID: 36605048 [TBL] [Abstract][Full Text] [Related]
35. Scleral fixation of dexamethasone intravitreal implant (OZURDEX®) in a case of angle-supported lens implantation. Mateo C; Alkabes M; Burés-Jelstrup A Int Ophthalmol; 2014 Jun; 34(3):661-5. PubMed ID: 23928945 [TBL] [Abstract][Full Text] [Related]
36. Economic evaluation of a fluocinolone acetonide intravitreal implant for patients with DME based on the FAME study. Cutino A; Green K; Kendall R; Moore PT; Zachary C Am J Manag Care; 2015 Jan; 21(4 Suppl):S63-72. PubMed ID: 25734663 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of the clinical effectiveness in routine practice of fluocinolone acetonide 190 µg intravitreal implant in people with diabetic macular edema. Holden SE; Currie CJ; Owens DR Curr Med Res Opin; 2017 Oct; 33(sup2):5-17. PubMed ID: 28881149 [TBL] [Abstract][Full Text] [Related]
39. Patterns of retinal thickness prior to and following treatment with fluocinolone acetonide 190 µg intravitreal implant for diabetic macular edema. Currie CJ; Holden SE; Owens DR Curr Med Res Opin; 2017 Oct; 33(sup2):33-43. PubMed ID: 28881150 [TBL] [Abstract][Full Text] [Related]
40. Corticosteroids for Diabetic Macular Edema. Chawan-Saad J; Wu M; Wu A; Wu L Taiwan J Ophthalmol; 2019; 9(4):233-242. PubMed ID: 31942428 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]